A recent study found a potential breakthrough for treatment of Graves’ disease, an illness which is diagnosed to roughly 1 million Americans annually and has symptoms which affect the eyes.
The new treatment aims to block collagen production and combat two symptoms of Graves’ disease, excessive scarring and tissue remodeling.
New findings show promise for treatment of Graves’ disease and other ocular disorders